
|Podcasts|July 29, 2022
Pharmacy Focus: Psychedelic Pharmacy - Investigating Ketamine for Chronic Pain Management, Addiction Treatment
This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about ketamine and the future of the opioid epidemic.
Advertisement
This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about how investigative psychedelic treatments could help treat both chronic pain as well as addiction, and what this could mean for the future of the opioid epidemic.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Boosters: Responding to Supplement Marketing Claims and Safety Questions
2
Oral GLP-1 Orforglipron Approved for Obesity
3
White House Expands TrumpRx, Adding Over 600 Generic Medications
4
Why Drug Information Infrastructure—Not Model Size—Will Define the Future of Health Care AI
5


































































































































